IMMUNE CHECKPOINT INHIBITOR
Clinical trials for IMMUNE CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
AI vs. liver cancer: can computers pick who needs treatment?
Disease control Not yet recruitingThis study aims to see if an artificial intelligence (AI) model can better identify which liver cancer patients need immunotherapy after surgery to prevent the cancer from coming back. It will follow 300 patients who have had their liver tumors surgically removed. The AI will ana…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Fungus-Based pill joins forces with radiation to fight tough cancers
Disease control Not yet recruitingThis study is testing a combination treatment for people with advanced solid tumors that have spread or returned. It combines a pill made from a natural fungus compound (PRaG-1) with targeted radiation, immune-boosting injections, and standard immunotherapy drugs. The main goal i…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Do painkillers interfere with cancer treatment?
Knowledge-focused Not yet recruitingThis study aims to understand if common opioid pain medications affect how well immunotherapy works for advanced lung cancer. Researchers will follow 100 patients with significant pain who are receiving both immunotherapy and opioids. The goal is to see if pain levels or the pain…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Hubei Cancer Hospital • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC